Natural Products Drug Discovery and Therapeutic Medicine
A fresh examination of the past successes of natural products as medicines and their new future from both conventional and new technologies. High-performance liquid chromatography profiling, combinatorial synthesis, genomics, proteomics, DNA shuffling, bioinformatics, and genetic manipulation all no...
Saved in:
Other Authors: | , |
---|---|
Format: | Book |
Language: | English |
Published: |
Totowa, N.J.
HUMAN PRESS
2005
|
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000#i 4501 | ||
---|---|---|---|
001 | wils-333804 | ||
005 | 202111914812 | ||
008 | 211209t2005 NJU ag# ##001 #deng#D | ||
020 | # | # | |a 1592599206 |q alk. paper |
020 | # | # | |a 1588293831 |q alk. paper |
040 | # | # | |a DNLM/DLC |b eng |c DLC |d UiTM |e rda |
090 | 0 | 0 | |a QV752 |b N285 2005 |
245 | 0 | 0 | |a Natural Products |b Drug Discovery and Therapeutic Medicine |c Edited by Lixin Zhang, PhD; Arnold L. Demain, PhD |
264 | # | 1 | |a Totowa, N.J. |b HUMAN PRESS |c 2005 |
264 | # | 4 | |c ©2005 |
300 | # | # | |a xiv, 382 pages |b illustrations |c 26 cm |
336 | # | # | |a text |2 rdacontent |
337 | # | # | |a unmediated |2 rdamedia |
338 | # | # | |a volume |2 rdacarrier |
504 | # | # | |a Includes bibliographical references and index |
520 | # | # | |a A fresh examination of the past successes of natural products as medicines and their new future from both conventional and new technologies. High-performance liquid chromatography profiling, combinatorial synthesis, genomics, proteomics, DNA shuffling, bioinformatics, and genetic manipulation all now make it possible to rapidly evaluate the activities of extracts as well as purified components derived from microbes, plants, and marine organisms. The authors apply these methods to new natural product drug discoveries, to microbial diversity, to specific groups of products (Chinese herbal drugs, antitumor drugs from microbes and plants, terpenoids, and arsenic compounds), and to specific sources (the sea, rainforest, and endophytes). These new opportunities show how research and development trends in the pharmaceutical industry can advance to include both synthetic compounds and natural products, and how this paradigm shift can be more productive and efficacious. |
650 | 1 | 2 | |a Drug Design |
650 | 2 | 2 | |a Biological Products |x therapeutic use |
650 | 2 | 2 | |a Biological Factors |x therapeutic use |
700 | 1 | # | |a Demain, A. L. |c Ph. D |d 1927- |e edited |q Arnold L. |
700 | 1 | # | |a Zhang, Lixin, |c Ph. D |e edited |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=333804 |
998 | # | # | |a 00250##a002.5.2||00250##b002.5.3||00255##a007.25.3||00260##a002.8.2||00260##b002.8.4||00260##c002.7.6||00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00500##a002.17.2||00502##a007.9.2||00520##a007.2||00520##b007.2||00538##a003.16.9||00546##a006.11||00730##a006.2.2||00730##d006.4||00730##f006.10||00730##n006.2.2||00730##p006.2.2|| |